Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion type Assertion NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_head.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion description "[Primary (de novo) glioblastomas develop in older patients and are characterized by epidermal growth factor (EGF) receptor amplification/overexpression, p16 deletion, and PTEN mutations, whereas secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma develop in younger patients and frequently contain p53 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_provenance.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion evidence source_evidence_literature NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_provenance.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion SIO_000772 10666371 NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_provenance.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion wasDerivedFrom befree-20140225 NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_provenance.
- NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_assertion wasGeneratedBy ECO_0000203 NP315311.RAkiBH9B7aGpW1Aj4nq6ccX4sKw_WMbFRIcGm8450ZDgY130_provenance.